Please login to the form below

Not currently logged in
Email:
Password:

atacicept

This page shows the latest atacicept news and features for those working in and with pharma, biotech and healthcare.

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did

Latest news

  • Lupus – a 'great imitator'

    Atacicept is unique in that it is being developed solely for the treatment of lupus. ... Lupus nephritis trials have largely been unsuccessful, therefore it is hoped that, with the change in patient population, atacicept will show some efficacy in these

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics